Genetic sonogram scoring index: Accuracy and clinical utility

Journal of Ultrasound in Medicine

Volumn 18, Issue 8, 1999, Pages 523-528

  Bromley, Bryann ^a,b   Shipp, Thomas ^a   Benacerraf, Beryl R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Diagnostic Ultrasound Associates   (United States)

Author keywords

Down syndrome; Genetic sonogram scoring index; Sonogram, genetic

Indexed keywords

FETAL MONITORING; MEDICAL IMAGING; OBSTETRICS;

GENETIC SONOGRAM;

ULTRASONIC IMAGING;

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; GENETIC ANALYSIS; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM;

EID: 0032798154     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.1999.18.8.523     Document Type: Article

References (19)

1. Benacerraf BR, Neuberg D, Bromley B, et al: Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 11:449, 1992
2. Benacerraf BR, Nadel A, Bromley B: Identification of second-trimester fetuses with autosomal trisomy by use of a sonographic scoring index. Radiology 193:135, 1994
3. Bromley B, Lieberman E, Benacerraf BR: The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome. Ultrasound Obstet Gynecol 10:321, 1997
4. Vintzileos AM, Guzman ER, Smulian JC, et al: Choice of second-trimester genetic sonogram for detection of trisomy 21. Obstet Gynecol 90:187, 1997
5. Vintzileos AM, Egan JFX: Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 172:837, 1995
6. Vinzileos AM, Campbell WA, Rodis JF, et al: The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 87:948, 1996
7. Vintzileos AM, Egan JFX, Smulian JC, et al: Adjusting the risk for trisomy 21 by a simple ultrasound method using fetal long-bone biometry. Obstet Gynecol 87:953, 1996
8. Vintzileos AM, Egan JFX: Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 172:837, 1995
9. Nadel AS, Bromley B, Frigoletto FD Jr, et al: Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med 14:297, 1995
10. Nyberg DA, Luthy DA, Resta RG, et al: Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 12:8, 1998
11. Benacerraf BR, Neuberg D, Frigoletto FD: Humeral shortening in second trimester fetuses with Down syndrome. Obstet Gynecol 77:223, 1991
12. Benacerraf B, Gelman R, Frigoletto F: Sonographic identification of second-trimester fetuses with Down's syndrome. N Engl J Med 317:1376, 1987
13. Vintzileos AM, Campbell WE, Guzman ER, et al: Second-trimester ultrasound markers for detection of trisomy 21: Which markers are best? Obstet Gynecol 89:941, 1997
14. Deren O, Mahoney MJ, Copel JA, et al: Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate? Am J Obstet Gynecol 178:441, 1998
15. Drugan A, Johnson MP, Reichler A, et al: Second-trimester minor ultrasound anomalies: Impact on the risk of aneuploidy associated with advanced maternal age. Obstet Gynecol 88:203, 1996
16. Benacerraf BR, Harlow BL, Frigoletto FD: Hypoplasia of the middle phalanx of the fifth digit: A feature of the second trimester fetus with Down syndrome. J Ultrasound Med 9:389, 1990
17. Nyberg DA, Luthy DA, Cheng EY, et al: Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 193:1030, 1995
18. Bahado-Singh RO, Goldstein I, Uerpairojkit B, et al: Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results. Am J Obstet Gynecol 173:1106, 1995
19. Yagel S, Anteby EY, Hochner-Celnikier D, et al: The role of midtrimester targeted fetal organ screening combined with the "triple test" and maternal age in the diagnosis of trisomy 21: A retrospective study. Am J Obstet Gynecol 178:40, 1998